Skip to content

Rhythm Pharmaceuticals, Inc.

RYTM· NasdaqCore metricsCIK 1649904

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -2.15%
Market cap
$7.61B
69.33M shares
Filings
839
$92.13M
Q3 2026+45.8% FY25 yoy
-$41.37M
Q3 2026N/M FY25 yoy
-$39.27M
Q3 2026N/M FY25 yoy
-$56.90M
Q3 2026derivedN/M FY25 yoy
-$0.61
Q3 2026N/M FY25 yoy
$39.98M
Q3 2026−39.1% FY25 yoy
$7.61B
—
27.1×
86.5×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$109.77+10.06%+$10.03past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$189.76MFY 2025
$189.76M0FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$189,757,000reported
FY 20242024-12-31$130,126,000reported
FY 20232023-12-31$77,428,000reported
FY 20222022-12-31$23,638,000reported
FY 20212021-12-31$3,154,000reported
FY 20202020-12-31$0reported
FY 20192019-12-31$0reported
FY 20182018-12-31$0reported
FY 20172017-12-31$0reported
FY 20162016-12-31$0reported

Segments

Revenue by Geography, FY2021 to FY2024FY2021United States · FY2021 · $3.15MFY2022United States · FY2022 · $21.08MInternational · FY2022 · $2.56MGermany · FY2022 · $954.00KOther · FY2022 · $1.61MFY2023United States · FY2023 · $62.43MInternational · FY2023 · $15.00MGermany · FY2023 · $6.08MOther · FY2023 · $8.93MFY2024United States · FY2024 · $96.11MInternational · FY2024 · $34.02M
LineFY2024ShareChange
United States$96.11M74%+54.0%
International$34.02M26%+126.7%
Germany———
Other———
Total$130.13M

From the 10-K filed Feb 28, 2025RYTM

Pharmaceutical preparations

Rhythm Pharmaceuticals, Inc. is the 85th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR